chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 58-year-old female patient who received for prophylaxis. Previously experienced adverse reactions included rash (in the past from a band aid). Concurrent medical conditions included shingles (the patient had mild shingles at the age 50 years). On 26th April 2018 14:00, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In April 2018, less than a day after receiving SHINGRIX, the patient experienced fever. On 26th April 2018, the patient experienced muscle pain, erythematous rash, general body pain, itchy rash, pain in arm, injected limb mobility decreased, feeling abnormal, headache, pain of skin and injection site pain. On an unknown date, the outcome of the muscle pain, erythematous rash, fever, general body pain, itchy rash, pain in arm, injected limb mobility decreased, feeling abnormal, headache and pain of skin were recovered/resolved and the outcome of the injection site pain was unknown. It was unknown if the reporter considered the muscle pain, erythematous rash, fever, general body pain, itchy rash, pain in arm, injected limb mobility decreased, feeling abnormal, headache, pain of skin and injection site pain to be related to SHINGRIX. Additional details were received as follows: The patient reported that she was petite and received SHINGRIX in right deltoid at 2 pm. The patient's side effects with previous vaccinations lasted a couple of days and then fade away.  The patient experienced muscle ache within a few hours with a headache on the same day of vaccination. The patient had a rash later in the evening with an itchy arm. The patient reported that most of her side effects occurred in the evening of the vaccination. The patient also reported that SHINGRIX vaccine affected her more strongly than previous vaccinations. She reported a headache, low grade fever for a couple of days with body aches and sore skin like a flu. The patient had muscle soreness, her whole arm hurt and she had no full range of motion and couldn't raise her arm all the way up. The patient reported that the vaccine hurt like heck when she initially got vaccination and the it went away. The patient was feeling icky and she had a rash on the side of her arm near the dent in her arm or muscle. The patient described the rash as a half bend around her right arm that was red and itchy and didn't spread and it took one week to resolve all the symptoms. The rash never moved or spread. They put a band aid on her arm after vaccination and she had previously experienced a rash from a band aid in the past.
Information has been received from a front desk clerk from the office of a physician via a company representative, referring to a 12 year old female patient. Information of concurrent condition, medical history and concomitant therapy was not provided. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9 (route, lot# and expiration date unknown) for prophylaxis. It was the only vaccine the patient was administered. On an unknown date, the patient experienced an episode of syncope at the front desk. The outcome of the event was unknown. The causality was not provided.
Onset of (L) shoulder pain/heaviness day following vaccine. Persistent pain in (L) arm, exam findings of impingement in (L) shoulder 1 month after vaccine.
pt received Adacel vaccine in right deltoid 7/7/22 at 2:00pm and did not notice any redness, swelling or bruising at time of administration. Pt applied ice packs to injection site ~ 3:00pm that day then that evening at 6:00pm onset of headache, abdominal pain, diaphoresis, temperature: 100 degrees F. Then 7/8/22 & 7/9/22 had diarrhea and on 7/9/22 right arm became sore like a bruise for several days. On 7/11/22 cramping returned and onset of black diarrhea. Pt states he has had cramping & black diarrhea several times per year x 5 years & usually lasts 3 days then resolves on its own. Pt called Employee Health on 7/14/22 reporting these symptoms as side effects to Tdap vaccine on 7/7/22. Pt  called in sick from 7/8/22, 7/11/22 through 7/13/22 and returned to work 7/14/22. Today 7/25/22 patient says all symptoms fully resolved 7/15/22 and 7/14/22 Urgent Care visit check his black stool and found no blood.
Muscles started to ache - then eyes started to burn they were red and slightly swollen - then that evening I itched all over severe. By the next morning I was still ache and eyes extremely red and slightly swollen.
Dialysis pt who prev had been receiving Recombivax recvd vax 24DEC94 & w/in 72 hrs devel diffuse rash over body w/sloughing skin;pt was adm to hosp;reporter is not certain if pt was hospitalized for the rash or for some other reason;
Patient presented to emergency department on 10/6/2021 with worsening shortness of breath, loss of taste and smell, congestion, and cough that started 9/24/2021. He was found to be COVID-19 positive on 9/27/2021. He was found to be hypoxic and tachypneic in the ED and was admitted for further management. Patient was treated with dexamethasone and required 4L of oxygen. He was discharged home on 10/11/2021 without need for additional supplemental oxygen.
Information has been received from a registered nurse concerning a patient who on 18-MAY-2010 was inadvertently vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck) due to a human error. No adverse effect reported. Follow up information has been received from the registered nurse who reported that the patient called to the office on 21-MAY-2010 and complained of swelling, red streak and itchiness. All effects were starting to go away. There was no treatment. The nurse stated the patient had allergy to cefaclor. Additional information has been requested.
WIDESPREAD DARK RED, ITCHY RASH OVER ENTIRE RIGHT SIDE INCLUDING THE ARM, TORSO, STOMACH, BACK, NECK, EARS.   TREATED WITH ORAL BENADRYL CAPSULES. SYMPTOMS RESOLVED WITHIN 24 HOURS.  NO FURTHER MEDICAL TREATMENT SOUGHT.
Vaccine expired 07/05/22. Administered 07/07/22. No adverse signs or symptoms.
This spontaneous report was received from a nurse, referring to a 6 year old patient of unknown gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported. On 28-NOV-2017, the patient was vaccinated with GARDASIL 9 lot # M030380, expiration date 01-FEB-2019, for prophylaxis (strength, dose, route and frequency, were not reported). No adverse effects were reported.
Pt recvd vax & was hospitalized for sz; unusual cry, unresponsive disoriented; post ictal, resp depression, hypotonic & decerebrate, ataxic & agitated; febrile convulsion, status epilepticus, crying, CBC revealed a white count of 3800, t103
This is a spontaneous report from a contactable physician through a Pfizer sales representative. A patient of unspecified age, ethnicity and gender received a single dose of PREVNAR 13, via an unspecified route of administration on an unspecified date. Medical history and concomitant medications were not reported. The patient experienced a cellulitis reaction on an unspecified date with outcome of unknown.
Patient writes that he received the 5th anthrax vaccination.  As he was leaving the airplane after a flight on the night of the 10/26/2004, I abruptly noticed a pain in my left shoulder.  Due to a surgery performed on the shoulder over 20 years prior, I suspected a problem with the earlier repair.  X-rays and an MRI indicated no damage to the repair, but a case of bursitis.  Doctor administered an injection of Depmedrol and prescribed a course of steroids and Celebrex.  Within 10 days of the treatment my shoulder was back to normal.  I did not initially associate this problem with the anthrax shot, as I had no particular reaction at the time of the vaccination and no reason to suspect it had caused the bursitis.  In July 2005, I was beset by symptoms indicative of severe rheumatoid arthritis.  During the six months since this condition started, I have had bursitis in one or both shoulders on three occasions.  I am convinced that this condition and the first case of bursitis are a reaction to the anthrax vaccination reported.  Treatment to date has included varying dosages of Prednisone, NSAIDs, and narcotic pain relievers.  Since August 05, the dosage of Prednisone I was taking was decreased overtime from 40mg per day to 10mg.  Since 10/29/2005, I am no longer taking steroids.  I am using Sulindac, maximum dosage of Tylenol and Lortab.  This regimen is not as effective at relieving the symptoms as the Prednisone had been, but I have been able to tolerate the situation.  No tests to date have shown any joint damage.  Initially, and on several occasions later during periods when I had not been taking steroids, the ESR was shown to be elevated in my blood tests.  I saw a rheumatologist who did not think I had arthritis and suggested that I see an oncologist.  The oncologist I was referred to found nothing to suggest any form of cancer.  I was then referred to an internal medicine doctor, he subsequently referred me to a rheumatology doctor.  On 01/03/2006 the rheumatologist decided on a diagnosis of reactive arthritis (post-viral arthritis, specifically).  I am scheduled  for a followup appointment in May of 2006.  In light of the tests done to date and my lack of recovery, I considered this diagnosis to be less than credible.
3/2/21-Covid Vaccine #1-From the first Covid Vaccine dose developed chills/aches and sore arm  within 24 hours and the Covid arm rash at the injection site a week after the shot.  3/30/21-Covid Vaccine #2-From the second Covid Vaccine dose developed the Covid arm rash within 24 hours and two weeks later have now developed severe dizziness/vertigo that has persisted for 4 days and has not yet gone away.
received an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a adult male patient who received HAV (Havrix) (batch number 3F349, expiry date 9th August 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 02-Sep-2022 Reporter's Comment: The reporter reported that a patient received an expired dose of Havrix vaccine. The reporter consented to follow up. Additional Supportive Information: The patient received an expired dose of Havrix vaccine which led to expired vaccine used.
The pt was given a TD vax and experienced a large baseball sized reaction and a swollen arm.
Dizzy Body aches Injection swell with knot, hurts. Feel real Bad. Body aches, fever Muscle & joint pain
Saw mom at pt's kindergarten screening 4/10/03. She informed RN pt had a cerebellar stroke 3/25/03 3-4 days before this, he had "slight viral symptoms"- runny nose, cough, "little fever" - never measured but stated probably not over 100 degrees. Mom picked pt up from babysitter's house 3/25/03 and pt had acute vertigo, nausea and vomiting, and complaints of headache. According to babysitter, this was sudden onset, he had ate and played fine all day. Mom brought pt straight to primary care physician's office. Mom and MD questioned acute labyrhinitis. The next afternoon 3/26/03, pt complained terrible headache and mom brought him to emergency dept. CAT scan and MRI done-transferred by ambulance to hospital. Stayed on a "safe and sound" floor until next morning 3/27/03, then seen by neurosurgeon and repeat MRI done-revealed cerebellar stroke. Transferred to ICU floor and medically managed there until Mar. 30 when transferred to regular medical floor until discharge-April 1, 2003. Never ruled out cause-? congenital circulatory problems of circle of willis, vasculitis/arteritis, viral, ? etc. It was an ischemic stroe, no hemorrhagic.
Sore Throat, congestion, runny nose, fatigue, flu-like symptoms. Lasted a week and was lessened with Flonase and Claritin.
redness,itching,rash. Took shot on 11/22/99, within 12 hrs had the above symptoms. This is my 5th shot in the series, but my first adverse reaction.
Systemic: Fainting / Unresponsive-Mild, Additional Details: HE FAINTED EVERY TIME GETS VACINATION
Atopic dermatitis worse since vaccine; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Atopic dermatitis worse since vaccine) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026b21a and 017c21a) for COVID-19 vaccination.     Concurrent medical conditions included Atopic dermatitis. Concomitant products included DUPILUMAB (DUPIXENT) for Atopic dermatitis.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (Atopic dermatitis worse since vaccine). At the time of the report, CONDITION AGGRAVATED (Atopic dermatitis worse since vaccine) had not resolved.
redness & soreness lt arm p/vax;redness approx size of baseball upper rt arm, soreness, painful, warmth & small amount edema used ice pack for 1 day advised to call PMD;
Chest discomfort, acute onset of substernal chest discomfort radiating to the back.
9/19/08 MOM PHONED AND CHILD'S RT. ARM IS REDDENED AND WARM TO TOUCH.  THE REDNESS BEGAN EARLY THIS AM. CHILD BROUGHT TO HD AND RT. DELTOID AREA IS RED, WARM TO TOUCH.  NO MEDS HAVE BEEN GIVEN, GABVE MOTHER ACETOMINOPHEN AND INSTRUCTIONS TO GIVE EVERY 4 TO 6 HOURS WHILE AWAKE FOR NEXT 24-48 HOURS.
Thrombocytopenia, unspecified on 2023-08-24, Thrombocytopenia, unspecified on 2023-08-30.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 9:41 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 9:38 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 02-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 65.89 for dose administered on 02-Mar-2021 and 65.97 for dose administered on 30-Mar-2021.  No concomitant medications were reported.  Vial was moved to fridge on 24-Feb-2021. Product moved to clinic on 02-Mar-2021. Batch number 014M20A underwent temperature excursion on 02-Mar-2021 with temperature 27 degrees Fahrenheit from 09:00 AM to 10:00 AM. Beyond use date for the vial was reported as 26-Mar-2021.   Vial was moved to fridge on 23-Mar-2021. Product moved to clinic on 30-Mar-2021. Batch number 019B21A underwent temperature excursion on 30-Mar-2021 with temperature 33 degrees Fahrenheit from 09:00 AM to 10:00 AM. Beyond use date for the vial was reported as 22-Apr-2021.   Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Patient was recently diagnosed with Bell's palsy to the right side of her face. She was sent from Hospital to Hospital with symptoms of CVA. After seeing neurology at Hospital she was diagnosed with Bell's palsy and discharged home on oral prednisone.
Cardiac Arrest at 1:30 pm on 4/30/2021.   .  Arrest was witnessed by family and Emergency Medical Personnel.   Cardiopulmonary Resuscitation was initiated.  Pt was very anxious when EMS arrived.
was diagnosed with COVID19 one week after receiving the first dose of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (was diagnosed with COVID19 one week after receiving the first dose of the vaccine) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced COVID-19 (was diagnosed with COVID19 one week after receiving the first dose of the vaccine). The patient was treated with IVERMECTIN for Adverse event, at an unspecified dose and frequency and HYDROXYCHLOROQUINE for Adverse event, at an unspecified dose and frequency. At the time of the report, COVID-19 (was diagnosed with COVID19 one week after receiving the first dose of the vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by reporter.Treatment includes use of antibiotics. The patient was diagnosed with COVID19 one week later.
ISSUES WITH ARTHRITIS/JOINTS; SKIN BREAKOUT; This spontaneous report received from a patient concerned an adult female. The patient's height, and weight were not reported. The patient's concurrent conditions included: moderate to severe chronic plaque psoriasis, and psoriatic arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: adalimumab (solution for injection in pre-filled syringe, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for moderate to severe chronic plaque psoriasis, and psoriatic arthritis. No concomitant medications were reported.  On an unspecified date, the patient experienced issues with arthritis/joints, and skin breakout. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with adalimumab was not reported. The patient had not recovered from issues with arthritis/joints, and skin breakout. This report was non-serious.
Mother asked for Pfizer vaccine however Moderna was inadvertently administered. Both mother and patient were advised of the error immediately after vaccination was given. The correct dose of Moderna was given to the patient and she had no adverse reactions.
This case was reported by a physician via sales rep and described the occurrence of injection site rash in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site rash and vesicular rash. On an unknown date, the outcome of the injection site rash and vesicular rash were recovered/resolved. It was unknown if the reporter considered the injection site rash and vesicular rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. After receiving SHINGRIX, the patient had a skin reaction at injection site. There was a bubbly rash that lasted a week.
This spontaneous report as received from a health professional on 14-NOV-2014 refers to unspecified patients. On unknown dates the patients were vaccinated with doses of PROQUAD (Merck) (lot #, expiration date and route unspecified) which had been exposed to temperature excursions that were supported, since the first temperature excursion on 28-OCT-2014. No adverse experiences had been observed or reported. This is one of several reports received from same source. Additional information has been requested.
A pharmacist reported a pt received a vaccine, shortly after injection the pt developed a raised hive at the injection site.
bruising/rash on both arms, right finger, right breast, left upper leg ongoing at 10 days.  Increased resting heart rate, unexplained blood readings out of range, no ER Doctor available to explain results nurse could not explain in ER waiting area.  Itching at bruise areas about 5 days later.  Still bruised at day 10.